Explore

Rapid Read Rapid Read
South Carolina Public Health Reports No New Measles Cases, Potential End to Outbreak Nears

South Carolina Public Health Reports No New Measles Cases, Potential End to Outbreak Nears

The South Carolina Department of Public Health (DPH) has reported no new measles cases as of April 14, 2026, indicating a potential end to the state's measles outbreak. The outbreak, which began in October 2025, has become the largest in the U.S. since the disease was declared eliminated in 2000. The total number of cases has plateaued at 997, with Spartanburg County being the epicenter, accounting for 940 cases. The DPH credits increased vaccination rates in January and February for the slowdown in new cases. The outbreak could officially end by April 26 if no new cases are reported, as a 42-day period without new infections is required to declare the outbreak over.
Trendline Trendline
Rising Popularity of Dietary Supplements Raises Health and Regulatory Questions

Rising Popularity of Dietary Supplements Raises Health and Regulatory Questions

Rising Popularity of Dietary Supplements Raises Health and Regulatory Questions
AP News AP News
WHO says vaccinations saving millions in Africa, but U.S aid cuts and Iran war threaten progress

WHO says vaccinations saving millions in Africa, but U.S aid cuts and Iran war threaten progress

The World Health Organization says vaccination programs across Africa have saved more than 50 million lives over the past five decades, but progress is slowing in some countries
Rapid Read Rapid Read
FDA Criticizes Clinical Trial Sponsors for Lack of Transparency, Threatens Non-Compliance Notices

FDA Criticizes Clinical Trial Sponsors for Lack of Transparency, Threatens Non-Compliance Notices

The FDA has initiated a campaign to ensure clinical trial sponsors disclose the results of their studies, highlighting that approximately one-third of trials remain unreported. The agency has sent reminders to around 2,200 product manufacturers and researchers about their obligation to report study results to the clinicaltrials.gov database. According to the FDA, 29.6% of clinical trials that are likely subject to mandatory reporting have not uploaded their results. This lack of transparency has been a contentious issue in the pharmaceutical industry, with the FDA previously issuing warning notices to companies and researchers who failed to comply with federal law. Current U.S. regulations require that results from phase 2 to 4 trials of FDA-regulated drugs, biologics, and devices be reported within 12 months of the study's primary completion date. The FDA has warned that failure to meet these standards could result in notices of non-compliance, potentially leading to fines.
Rapid Read Rapid Read
CDC Reports Gastrointestinal Illness Outbreak on Oceania Cruise Ship Affecting Over 20 Individuals

CDC Reports Gastrointestinal Illness Outbreak on Oceania Cruise Ship Affecting Over 20 Individuals

More than 20 individuals, including guests and crew members, have fallen ill with gastrointestinal symptoms aboard the Oceania Insignia cruise ship. The Centers for Disease Control and Prevention (CDC) reported that the main symptom experienced by those affected was diarrhea, although the exact cause of the outbreak remains unknown. The ship, which carried 633 guests, completed its voyage on April 14, 2026, after departing from Panama City on April 4. The cruise included stops in Colombia, Curaçao, Aruba, and Jamaica. In response to the outbreak, Oceania Cruises has implemented enhanced disinfection and cleaning protocols and isolated those who are sick. This incident is part of a broader trend of gastrointestinal illnesses on cruise ships, with the CDC noting three such outbreaks this year that met its threshold for public notification.
Rapid Read Rapid Read
Study Reveals Unexpected Detection of Tuberculosis DNA in US-Born Patients

Study Reveals Unexpected Detection of Tuberculosis DNA in US-Born Patients

A recent study has uncovered an unexpectedly high prevalence of Mycobacterium tuberculosis DNA in respiratory samples from predominantly US-born patients hospitalized in Boston. The research, conducted over six years, utilized the 'Totally Optimized PCR (TOP) TB assay,' an ultrasensitive molecular assay, to detect TB-DNA in 12 to 16% of samples. This finding suggests a potential association between M. tuberculosis and various clinical syndromes in patients with a low pre-test probability of TB. The study highlights the need for more sensitive diagnostic tools to identify early stages of TB disease, as current methods may not detect low bacterial loads. The results, while preliminary, indicate a possible new variant of paucibacillary TB disease that remains unrecognized by existing diagnostic technologies.
Rapid Read Rapid Read
Skin Cancer Foundation Offers Free Screenings in Burlington

Skin Cancer Foundation Offers Free Screenings in Burlington

The Skin Cancer Foundation is set to provide free skin cancer screenings in Burlington, Vermont, later this month as part of its 2026 national tour. The screenings will be conducted in a 38-foot RV equipped with two private exam rooms, staffed by local volunteer dermatologists, physician associates, or nurse practitioners. The RV will be stationed at University Mall in South Burlington on April 24 and at the Greater Burlington YMCA on April 25, with screenings available from 10 a.m. to 4 p.m. on both days. The program operates on a first-come, first-served basis, and no appointments are necessary. Participants will also receive educational materials on skin cancer and sun protection samples.
Rapid Read Rapid Read
FDA Urges Over 2,200 Sponsors and Researchers to Disclose Clinical Trial Results

FDA Urges Over 2,200 Sponsors and Researchers to Disclose Clinical Trial Results

The U.S. Food and Drug Administration (FDA) has issued reminders to more than 2,200 medical product companies and researchers about their obligation to submit clinical trial results to ClinicalTrials.gov. This action addresses the issue of non-disclosure of trial results, which can lead to publication bias and a skewed perception of drug efficacy and safety. According to the FDA, nearly 30% of studies that should report results have not done so, particularly those involving FDA-regulated products. The agency's reminders aim to encourage voluntary compliance before considering further regulatory actions.
Rapid Read Rapid Read
FDA Urges Over 2,200 Sponsors to Disclose Clinical Trial Results, Addresses Publication Bias

FDA Urges Over 2,200 Sponsors to Disclose Clinical Trial Results, Addresses Publication Bias

The U.S. Food and Drug Administration (FDA) has reminded more than 2,200 medical product companies and researchers to submit clinical trial results to ClinicalTrials.gov. The agency highlights the issue of publication bias, where negative trial results are often not disclosed, leading to a skewed perception of drug efficacy and safety. The FDA's initiative aims to ensure transparency and improve public access to clinical data. The agency has sent messages to companies and researchers to encourage voluntary compliance with reporting requirements, emphasizing the ethical obligation to disclose all trial outcomes.
Rapid Read Rapid Read
New Study Suggests Waist Circumference as Key Indicator of Heart Disease Risk

New Study Suggests Waist Circumference as Key Indicator of Heart Disease Risk

A recent study presented at the American Heart Association's scientific conference challenges the traditional reliance on Body Mass Index (BMI) as a predictor of heart disease risk. The research, which involved approximately 2,000 adults over a seven-year period, found that central obesity measures, such as waist circumference and waist-to-height ratio, are more accurate indicators of heart disease risk than BMI. The study highlights that individuals with normal BMI can still be at significant cardiac risk if they have fat accumulation in the abdominal area. This visceral fat, which surrounds vital organs, is metabolically active and contributes to conditions like insulin resistance and high blood pressure, increasing the risk of heart failure. The study also noted that high levels of C-reactive protein (CRP), an inflammatory marker, were associated with reduced survival without heart failure.
Reuters Reuters
Mail-order dominates US abortion pill dispensing

Mail-order dominates US abortion pill dispensing

By Ahmed Aboulenein WASHINGTON, April 13 (Reuters) - U.S. pharmacies are largely filling prescriptions for the abortion pill mifepristone via mail-order in states permitting telehealth access to the medication, despite a 2023 FDA decision allowing retail pharmacies to dispense the drug, according to
Rapid Read Rapid Read
Fight For Air Climb Chicago 2026 Raises Over $250K for American Lung Association

Fight For Air Climb Chicago 2026 Raises Over $250K for American Lung Association

The Fight For Air Climb Chicago 2026 event successfully raised more than $250,000 for the American Lung Association. Participants in the event climbed both towers of the Prudential Plaza, covering a total of 99 floors and nearly 2,500 steps. This annual event is designed to raise awareness and funds for lung health and research. The funds collected will support the American Lung Association's mission to save lives by improving lung health and preventing lung disease through education, advocacy, and research.